Diagnostics, Vaccines and Immune Adjuvants

PAI Life Sciences Inc. specializes in the development of innovative biotherapeutics and vaccines aimed at addressing neglected tropical diseases. The company focuses on translational research, which bridges the gap between laboratory discoveries and clinical applications, ensuring that their products effectively reach patients in need. Their pipeline includes a range of products, such as vaccines and adjuvants for infectious diseases, with a particular emphasis on conditions like schistosomiasis, lymphatic filariasis, tuberculosis, and onchocerciasis. PAI Life Sciences is committed to serving underserved populations globally, leveraging their expertise to tackle challenges that have been historically overlooked by other organizations.

One of the notable initiatives by PAI Life Sciences is their collaboration with the Onchocerciasis Vaccine for Africa (TOVA) Initiative, where they are advancing two lead vaccine candidates, Ov-103 and Ov-RAL-2, which have shown promise in preclinical models. These candidates are designed to provide protective immunity against onchocerciasis, a disease that affects millions, particularly in sub-Saharan Africa. The company is also exploring novel approaches to vaccine development, including the use of adjuvants that enhance immune responses, and is actively engaged in clinical trials to evaluate the safety and efficacy of their vaccine candidates. Through these efforts, PAI Life Sciences aims to contribute significantly to global health by developing effective treatments for diseases that disproportionately impact vulnerable populations.

United States

PAI Life Sciences is a biotechnology company located in Seattle, WA, specialized in the developmental and translational research necessary to bring products from the laboratory to bedside. Its mission is to address neglected diseases throughout the world with the idea of “serving the underserved.” The company has developed novel protein biotherapeutics and has a pipeline of products ranging from infectious disease vaccines and adjuvants to therapeutics for cancer.

PAI LIFE SCIENCES INC

Company Details